January 4, 2024 News by Steve Bryson, PhD Age of onset of RRMS increased in Norway over past century: Study An increasing number of people in western Norway have been diagnosed with relapsing-remitting multiple sclerosisĀ (RRMS) after age 50 over the past century, according to a new population study. The rise was primarily driven by people being diagnosed at older ages, with the average age of onset rising from 28.6…
August 4, 2023 News by Steve Bryson, PhD US neurologists satisfied with current RRMS therapies: Report Neurologists in the U.S. are largely satisfied with current treatment options for relapsing-remitting multiple sclerosis (RRMS), but opportunities remain for therapies in development, according to a new report by Spherix Global Insights. In the report series, called RealTime Dynamix: Multiple Sclerosis (U.S.), an ongoing survey of healthcare…
July 25, 2022 News by Vanda Pinto, PhD ‘Brain Healthy Lifestyle’ May Help Prevent Disability Progression Leading a healthy cognitive and physically active lifestyle, including having a normal body weight and well-controlled blood pressure, may increase brain reserve ā the brain’s ability to adapt after damage ā and delay disability progression in multiple sclerosis (MS), according to a new study. The study, āLifestyle factors…
January 12, 2022 News by Yedida Y Bogachkov PhD Cognitive Dysfunction Found to Increase Risk of Death in MS Cognitive dysfunction in patients with multiple sclerosis (MS) is predictive of worse outcomes, including clinical progression of the disease and a higher risk of mortality, according to a new study. “This review revealed that cognitive dysfunction … was associated with higher odds of transitioning from [a] relapsingāremitting course to…
November 17, 2021 News by Somi Igbene, PhD Long-term Supplement Use May Improve Gait, Strength in RRMS Long-term use of a high-dose nutritional supplement containing specific antioxidant vitamins and omega-3 and omega-6 fatty acids may boost walking performance and other measures of functional capacity in people with relapsing-remitting multiple sclerosis (RRMS), a new study found. The study, āThe Effects of Specific Omega-3 and…
May 6, 2019 News by Marisa Wexler, MS #AANAM – IV Therapy May Be More Effective Than Oral Treatment in Younger RRMS Patients, Research Suggests Infusible disease-modifying treatment ā that is, therapies given intravenously ā might have greater benefits for younger people with multiple sclerosis (MS) than oral ones, new research suggests. The research was presented at the ongoing American Academy of Neurology (AAN)’s annual meeting (May 4-10) by Brandi Vollmer,…
February 22, 2019 Columns by John Connor Relapse, Relapse, Relapse Relapses can be sneaky. They can scythe you down. I’ve been dealing with multiple sclerosis (MS) since 2006 and I only consciously remember two relapses. The first relapseĀ was two years after I had been diagnosed with sclerosis. There was the possible hope from my first neurologist that nothing…
September 27, 2018 Columns by Jennifer (Jenn) Powell Navigating Roadblocks with SPMS I saw my neurologist earlier this week. After my work-up, we sat and discussed how well I manage my multiple sclerosis. How well? No comment. Suffice it to say this disease is a worthy adversary. I have been feeling a little funky since that appointment. I have been looking to…
August 17, 2018 News by Marta Figueiredo, PhD Most MS Patients OK With Intravenous Treatment Conditions, Study Suggests Most patients with multiple sclerosis (MS) are satisfied with the conditions of their intravenous therapy (administered directly into the bloodstream) and are very aware of the therapy’s safety,Ā according to a small Macedonian study. Also, establishing a specialized infusion center would substantially increase intravenous treatment satisfaction and adherence. The study, ā…